Breast cancer: T-DM1 - an important agent in the history of breast cancer management

Nat Rev Clin Oncol. 2017 Nov;14(11):651-652. doi: 10.1038/nrclinonc.2017.123. Epub 2017 Aug 8.

Authors

Otto Metzger-Filho¹, Eric P Winer¹

Affiliation

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA.

PMID: 28786416
DOI: 10.1038/nrclinonc.2017.123

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Ado-Trastuzumab Emtansine
Breast Neoplasms*
Capecitabine
Humans
Lapatinib*
Maytansine / analogs & derivatives
Trastuzumab

Substances

Lapatinib
Maytansine
Capecitabine
Trastuzumab
Ado-Trastuzumab Emtansine